These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 37842841)
21. Search of the p.M918T Mutation in the RET Oncogene in Mexican Adult Patients with Medullary Thyroid Carcinoma. Ruiz-Garcia E; Vidal-Millan S; Lopez-Yañez A; Torres JAP; Guadarrama-Orozco JA; Lino-Silva LS; Meneses-Garcia A; Astudillo-de la Vega H; Garcia MG Exp Clin Endocrinol Diabetes; 2017 Apr; 125(4):218-222. PubMed ID: 28166591 [TBL] [Abstract][Full Text] [Related]
22. Aggressive medullary thyroid cancer, an analysis of the Irish National Cancer Registry. Lennon P; Deady S; White N; Lambert D; Healy ML; Green A; Kinsella J; Timon C; O' Neill JP Ir J Med Sci; 2017 Feb; 186(1):89-95. PubMed ID: 27083464 [TBL] [Abstract][Full Text] [Related]
23. Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer. Sherman SI; Clary DO; Elisei R; Schlumberger MJ; Cohen EE; Schöffski P; Wirth LJ; Mangeshkar M; Aftab DT; Brose MS Cancer; 2016 Dec; 122(24):3856-3864. PubMed ID: 27525386 [TBL] [Abstract][Full Text] [Related]
24. T Cells Engineered to Express Immunoreceptors Targeting the Frequently Expressed Medullary Thyroid Cancer Antigens Calcitonin, CEA, and RET M918T. Erickson TA; Shih YP; Fass J; Jang M; Tran E Thyroid; 2022 Jul; 32(7):789-798. PubMed ID: 35587601 [No Abstract] [Full Text] [Related]
25. Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma. Heilmann AM; Subbiah V; Wang K; Sun JX; Elvin JA; Chmielecki J; Sherman SI; Murthy R; Busaidy NL; Subbiah I; Yelensky R; Nangia C; Vergilio JA; Khan SA; Erlich RL; Lipson D; Ross JS; Miller VA; Shah MH; Ali SM; Stephens PJ Oncology; 2016; 90(6):339-46. PubMed ID: 27207748 [TBL] [Abstract][Full Text] [Related]
26. Screening of RET gene mutations in Chinese patients with medullary thyroid carcinoma and their relatives. Wang J; Zhang B; Liu W; Zhang Y; Di X; Yang Y; Yan D Fam Cancer; 2016 Jan; 15(1):99-104. PubMed ID: 26254625 [TBL] [Abstract][Full Text] [Related]
27. A cohort study on 10-year survival of sporadic medullary thyroid carcinoma with somatic RET mutation. Chuang LL; Hwang DY; Tsai KB; Chan HM; Chiang FY; Hsiao PJ Kaohsiung J Med Sci; 2016 Nov; 32(11):545-551. PubMed ID: 27847096 [TBL] [Abstract][Full Text] [Related]
28. RET Proto-oncogene Gene Mutation Is Related to Cervical Lymph Node Metastasis in Medullary Thyroid Carcinoma. Wang S; Wang B; Xie C; Ye D Endocr Pathol; 2019 Dec; 30(4):297-304. PubMed ID: 31494787 [TBL] [Abstract][Full Text] [Related]
29. Variability in Medullary Thyroid Carcinoma in Mathiesen JS; Nielsen SG; Rasmussen ÅK; Kiss K; Wadt K; Hermann AP; Nielsen MF; Larsen SR; Brusgaard K; Frederiksen AL; Godballe C; Rossing M Front Endocrinol (Lausanne); 2020; 11():251. PubMed ID: 32411094 [No Abstract] [Full Text] [Related]
30. Medullary Thyroid Cancer - Feature Review and Update on Systemic Treatment. Dabelić N; Jukić T; Fröbe A Acta Clin Croat; 2020 Jun; 59(Suppl 1):50-59. PubMed ID: 34219884 [TBL] [Abstract][Full Text] [Related]
32. Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation. Jasim S; Ying AK; Waguespack SG; Rich TA; Grubbs EG; Jimenez C; Hu MI; Cote G; Habra MA Thyroid; 2011 Feb; 21(2):189-92. PubMed ID: 21186952 [TBL] [Abstract][Full Text] [Related]
40. RET gene mutation analysis and long-term clinical outcomes of medullary thyroid cancer patients. Prabhu M; Shakya S; Ballal S; Ahmed Shamim S; Bal C Nucl Med Commun; 2020 Nov; 41(11):1136-1142. PubMed ID: 32796450 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]